NO

Nick Olsen

Principal, Innovation Endeavors

San Francisco Bay Area

VC
Investor

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Research
Business Strategy
Leadership
Teamwork
Microsoft Excel
Tissue Engineering
Biomedical Engineering
Consulting
Problem Solving
Cell
Regenerative Medicine
Data Analysis
Engineering
Team Leadership
PowerPoint
Time Management
Microsoft Office
Public Speaking
Microsoft Word
Microsoft PowerPoint

Education

Lists including Nick

AH
AE
AF
AJ

Based in SF

3077 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Work Experience

IE
Innovation Endeavors

2021

  • Principal

    2023

    investing in biotech and healthcare

  • Senior Associate

    2022 - 2023

  • Associate

    2021 - 2021

CB
Character Biosciences

2025

  • Member Board of Directors

    2025

AT
Averna Therapeutics

2024

  • Member Board of Directors

    2024

TL
Tempus Labs, Inc.

2018 - 2021

  • Strategy and Operations

    2018 - 2021

    Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions and deliver personalized patient care.

B&
Bain & Company

2015 - 2018

  • Associate Consultant, Senior Associate Consultant

    2015 - 2018

ST
Spark Therapeutics, Inc.

2017 - 2017

  • Global Commercial

    2017 - 2017